F
42
-4
MDLZ
36
4
EW
40
2
PVH
63
5
BMY
43
8
AVY
74
2
EQT
19
-5
AA
38
3
ABBV
68
-3
AIV
60
3
EL
45
2
ACN
65
4
INTU
69
4
SLG
71
-4
FE
41
2
DRI
61
-2
AAPL
56
-3
GS
65
2
NOV
37
-2
USB
37
4
F
42
-4
MDLZ
36
4
EW
40
2
PVH
63
5
BMY
43
8
AVY
74
2
EQT
19
-5
AA
38
3
ABBV
68
-3
AIV
60
3
EL
45
2
ACN
65
4
INTU
69
4
SLG
71
-4
FE
41
2
DRI
61
-2
AAPL
56
-3
GS
65
2
NOV
37
-2
USB
37
4
Financhill
Back

Bombardier Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
59

BDRAF
Bombardier

Last Price:
64.76
Seasonality Move:
0.01%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Buy
59
Bombardier (BDRAF) is a Buy

Is Bombardier a Buy, Sell or Hold?

  • The current Bombardier [BDRAF] share price is $64.76. The Score for BDRAF is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • BDRAF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BDRAF Stock Price Chart

What is Bombardier's stock price today?

  • The Bombardier share price today is $64.76
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BDRAF is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

BDRAF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.6 Buy
Relative Strength Index (14 RSI): 63.23 Buy
Chaikin Money Flow: 344 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (59.72 - 66.24) Buy
Bollinger Bands (100): (37.07 - 57.61) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

BDRAF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 62.42 Buy
20-day SMA: 64.1 Buy
50-day SMA: 55.19 Buy
200-day SMA: 42.13 Buy
8-day EMA: 62.45 Buy
20-day EMA: 62 Buy
50-day EMA: 56.73 Buy
200-day EMA: 46.02 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Bombardier Earnings Growth & BDRAF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Bombardier Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):